Application no. and date | 16203748.5 (espacenet) (Federated) (European Patent Register), 20090116 | Patent/reg. no. and date | DK/EP 3219795, 20240313 | Publication date | 20170920 | Priority no. and date | US 22179 P, 20080118, US 99373 P, 20080923, US 110246 P, 20081031 | EP pub. no. and date |
EP 3219795 20170920 | Effective date | | Applicant/owner | BioMarin Pharmaceutical Inc., 105 Digital Drive
Novato, CA 94949, US | Applicant ref. no. | 1699221 | Inventor | VELLARD, Michel Claude, 191 Oak Drive
San Rafael, CA 94901, US, KOPPAKA, Vish, c/o Ultragenyx Pharmaceutical Inc. 60 Leveroni Ct.
Novato, CA 94949, US, PUNGNOR, Erno, 250 Castenada Drive
Milbrae, CA 94030, US, HAGUE, Charles, c/o BioMarin Pharmaceutical Inc. 105 Digital Drive
Novato, CA 94949, US, DVORAK-EWELL, Melita, 1268 12th Avenue
San Francisco, CA 91422, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 38/46 (2006.01) , C12N 9/16 (2006.01) , C12P 21/00 (2006.01) | Title | FREMSTILLING AF AKTIVE KRAFTIGT PHOSPHORYLEREDE HUMANE LYSOSOMALE SULFATASE-ENZYMER OG ANVENDELSER DERAF | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|